Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC.
Niemantsverdriet M, Schuuring E, Elst AT, van der Wekken AJ, van Kempen LC, van den Berg A, Groen HJM. Niemantsverdriet M, et al. Among authors: van der wekken aj, van kempen lc, van den berg a. J Thorac Oncol. 2018 Dec;13(12):e249-e251. doi: 10.1016/j.jtho.2018.07.103. J Thorac Oncol. 2018. PMID: 30467046 Free article. No abstract available.
A chronic obstructive pulmonary disease related signature in squamous cell lung cancer.
Boelens MC, Gustafson AM, Postma DS, Kok K, van der Vries G, van der Vlies P, Spira A, Lenburg ME, Geerlings M, Sietsma H, Timens W, van den Berg A, Groen HJ. Boelens MC, et al. Among authors: van der vlies p, van der vries g, van den berg a. Lung Cancer. 2011 May;72(2):177-83. doi: 10.1016/j.lungcan.2010.08.014. Epub 2010 Sep 15. Lung Cancer. 2011. PMID: 20832896
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study.
Groen HJ, Sietsma H, Vincent A, Hochstenbag MM, van Putten JW, van den Berg A, Dalesio O, Biesma B, Smit HJ, Termeer A, Hiltermann TJ, van den Borne BE, Schramel FM. Groen HJ, et al. Among authors: van den borne be, van putten jw, van den berg a. J Clin Oncol. 2011 Nov 10;29(32):4320-6. doi: 10.1200/JCO.2011.35.5214. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990410 Clinical Trial.
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor.
Hiltermann TJN, Pore MM, van den Berg A, Timens W, Boezen HM, Liesker JJW, Schouwink JH, Wijnands WJA, Kerner GSMA, Kruyt FAE, Tissing H, Tibbe AGJ, Terstappen LWMM, Groen HJM. Hiltermann TJN, et al. Among authors: van den berg a. Ann Oncol. 2012 Nov;23(11):2937-2942. doi: 10.1093/annonc/mds138. Epub 2012 Jun 11. Ann Oncol. 2012. PMID: 22689177 Free article.
1,184 results